BiomX CEO and Chairman resign; Michael Oster appointed new CEO, Amir Shalom joins board

BiomX Inc.

Jonathan Solomon resigned as CEO and director effective March 4, 2026; no disagreement with company.
Dr. Russell Greig resigned as Chairman and director effective same date; no disagreement cited.
Board appointed Michael Oster as CEO; previously CEO of Saffron Tech Ltd. and Sattivus Tech Corp.
Board appointed Amir Shalom as Class I director; operations manager at Barzilai Medical Center.
New committee assignments: Liat Bidas chairs Audit; Amir Shalom chairs Compensation; Liat Bidas chairs Nominating and Governance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.